Notwithstanding the world economic turbulence, the total production of branched chain amino acids (BCAAs) has remained on the rise in the past few years. In 2011, the global BCAAs output increased to over 7,000 tonnes, at about 3% CAGR during 2008-2011.
China, one of the world’s leading BCAAs producers, is successful at meeting the ever rising demand, both at home and especially from overseas, from the downstream businesses. The country’s output of BCAAs has grown by 500 tonnes to almost 5,000 tonnes in 2011 as compared to 2008. The BCAAs consumption market in China, though, remains quite small, which is mainly due to the lack of national standards in the chemical’s manufacture.
New market report “BCAAs Research in China” drawn up by CCM International Limited (CCM) provides a wealth of exclusive information and in-depth analysis on the global and Chinese market for BCAAs (including eucine, isoleucin and valine), covering its present status, besides describing the main changes that took place in the sector in recent years.
The study covers the recent government policies with respect to the domestic BCAAs industry; supply and demand situation during 2008-2012; top 5 producers of BCAAs, along with their sales channels and sales strategies; major 5 end-use segments of BCAAs in China; BCAAs price trend during 2008-2017; key influencing factors; cost analysis of the top 3 producers in China. Furthermore, the research study is supplemented with extensive forecasts on the BCAAs supply-demand balance up to 2017.
Leading companies profiled in the report include: Shine Star (Hubei) Biological Engineering Co., Ltd., Yichang Sanxia Pharmaceutical Co., Ltd., Wuhan Hongbo Biotechnology Co., Ltd., Wuxi Jinghai Amino Acid Co., Ltd., and Wuxi Enovo Chemical Co., Ltd.
Title: BCAAs Research in China
Published: January, 2013
Price: US$ 16,200.00
More China Market Research Reports by CCM Include:
More new market research reports by CCM can be found at http://marketpublishers.com/members/ccm_chem/info.html